Precision Medicine in Action: Launching Pharmacogenomics & Nutrigenomics in RSU Royal Prima, Medan
In Collaboration with RSU Royal Prima Medan
- Prof. Dr. Tommy Leonard, SH, M.Kn., President Director, PT Royal Prima, Tbk
- Dr. dr. Wienaldi, MKM, MQM, President Director, RSU Royal Prima
- Ridyawati, S.Ak, MM, General Manager, RSU Royal Prima
- Indrida Rahmi, SH, M.Kn., Corporate Secretary & Legal Officer, PT Royal Prima, Tbk
- Dr. Rebecca Tay, CEO, Global Precision Diagnostics
- Dr. Gew Soon Peng, COO, Global Precision Diagnostics
- Ms. Maria Phang, Operations Director, Global Precision Diagnostics
- Ms. Nanny Sukimin, CEO, Medis Online & Regional Account Lead, Global Precision Diagnostics
- Along with other distinguished guests and clinicians
The Health Landscape of Medan
With the introduction of Pharmacogenomics testing, patients in Medan can now receive:
● Genetic information to personalize medication choices
● Reduced risk of adverse drug reactions
● More precise, evidence-based care
Our Nutrigenomics testing further enables individuals to make informed decisions on nutrition, supplementation, and lifestyle, based on their unique genetic profile.
This partnership reflects a shared vision to transform diagnostics and preventive care across Indonesia, bringing us one step closer to a future where healthcare is more precise, predictive, and patient-centric.
We sincerely thank RSU Royal Prima, UNPRI, and all stakeholders who helped make this launch a success. Together, we are shaping the future of personalized healthcare, powered by science and grounded in compassion. It was also a true honour to visit Universitas Prime Indonesia (UNPRI), one of Sumatra’s top universities, and to witness their strong leadership and commitment to clinically accredited, patient-first solutions.
We’re humbled to share that Precision Diagnostics has been recognized as a company under Bio-based Accelerator Program under Bioeconomy Corporation, and has also been officially recognised by the Malaysia Book of Records for:
🏆 𝟏ˢᵗ Clinically Recommended Genome-Wide Pharmacogenomics (2023)
🏆 Largest Clinically Accredited PGx Campaign (2025, with Sunway Multicare Group)
Thank you to RSU Royal Prima, UNPRI, and all collaborators who made this possible. Together, we are shaping a future of healthcare that is precise, predictive, and personal.
About Universitas Prima Indonesia (UNPRI)
Universitas Prima Indonesia (UNPRI) is a leading private university in Medan, North Sumatra, offering a wide range of academic programmes across healthcare, science and technology, business, law, education, and other disciplines. The university is committed to excellence in education, research, and innovation.
About RSU Royal Prima
RSU Royal Prima is one of the largest private hospitals in Medan, North Sumatra, providing a comprehensive range of healthcare services. The hospital is supported by specialist and subspecialist care, emergency and intensive care services, diagnostic facilities, and modern medical technology.
About Precision Diagnostics
Precision Diagnostics is a precision medicine and genomic diagnostics organisation committed to translating advances in genomics into clinically meaningful healthcare solutions supported by clinical governance. Through its work in pharmacogenomics, precision oncology, genomic testing, clinical implementation, and international scientific collaboration, Precision Diagnostics aims to support safer, more personalised, and evidence-based patient care across Malaysia and the Asia-Pacific region.
